- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07564791
A Study to Evaluate the Effects of the Libido Lift Supplement on Libido and Sexual Desire in Men
April 27, 2026 updated by: Bio Nature Health
This study evaluates the effects of the Libido Lift supplement on libido and sexual desire in men aged 35-75 years.
Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed באמצעות questionnaires at multiple timepoints.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89118
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male
- Aged 35-75 years
- Low sexual desire or desire to improve libido
- Dissatisfaction with sex life or desire to improve intimacy
- Desire to improve energy, endurance, stamina
- Sexually active (≥2 times per week)
- Willing to comply with study requirements
- Generally healthy
- Resides in the United States
Exclusion Criteria:
- Recent surgery or major illness
- Heavy alcohol use
- Hormone-related medications
- Liver disease or hypertension
- Use of anticoagulants
- Allergies to ingredients
- Chronic conditions affecting participation
- Participation in another study
- History of substance abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Libido Lift Supplement
Participants receive Libido Lift supplement daily for 4 weeks.
|
Four capsules taken once daily in the morning with water.
|
|
Placebo Comparator: : Placebo
Participants receive placebo capsules daily for 4 weeks.
|
Four placebo capsules taken once daily in the morning with water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Libido and Sexual Desire Score
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
|
Libido and sexual desire will be assessed using study-specific self-reported questionnaires.
Questionnaire responses will be used to generate a score reflecting participants' level of libido and sexual desire.
Changes in scores over time will be used to evaluate the effect of the intervention.
Higher scores indicate greater libido and sexual desire.
|
Baseline, Week 1, Week 2, Week 3, Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-Reported Sexual Satisfaction
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
|
Assessed via questionnaire responses evaluating satisfaction with sexual experiences.
|
Baseline, Week 1, Week 2, Week 3, Week 4
|
|
Change in Self-Reported Intimacy
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
|
Measured using questionnaires assessing perceived emotional and physical intimacy.
|
Baseline, Week 1, Week 2, Week 3, Week 4
|
|
Change in Self-Reported Energy Levels
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
|
Assessed via questionnaire items evaluating perceived energy.
|
Baseline, Week 1, Week 2, Week 3, Week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 27, 2025
Primary Completion (Actual)
May 28, 2025
Study Completion (Actual)
May 28, 2025
Study Registration Dates
First Submitted
April 27, 2026
First Submitted That Met QC Criteria
April 27, 2026
First Posted (Actual)
May 4, 2026
Study Record Updates
Last Update Posted (Actual)
May 4, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20738
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Libido
-
BayerCompletedContraception | LibidoBelgium, Australia, Germany, Thailand, Spain, Austria, Italy
-
906 CMVI HoldingsCitruslabsActive, not recruitingLibido | Gastrointestinal Issues | IntimacyUnited States
-
Applied Science & Performance InstituteCompletedSexual Health | LibidoUnited States
-
The University of Texas Health Science Center,...Not yet recruitingSexual Dysfunction | Menopause | Testosterone Deficiency | Libido DisorderUnited States
-
TriHealth Inc.TriHealth Medical Education Research FundCompletedHypoactive Sexual Desire Disorder (HSDD) | Low Libido | Female Sexual Dysfunction (FSD)United States
-
University Hospital Inselspital, BerneUniversity of Zurich; University Hospital MuensterCompletedPolymorphism, Genetic | Libido | Receptors, Androgen | Androgen EffectSwitzerland
-
Monash UniversityCompletedQuality of Life | Menopausal Syndrome | Libido DisorderAustralia
-
Mohit KheraSprout Pharmaceuticals, IncTerminated
-
Radicle ScienceCompletedDepression | Fatigue | Anxiety | Menopause | Sleep Disturbance | Cognitive Function | LibidoUnited States
Clinical Trials on Dietary Supplement: Libido Lift
-
Bionos Biotech S.L.CompletedSkin Hydration in Healthy Volunteers | Skin Ageing | Facial Wrinkles - Rough Texture - HyperpigmentationSpain
-
University of Novi Sad, Faculty of Sport and Physical...Completed
-
Fonterra Research CentreCompleted
-
Biosearch S.A.Universidad de Granada; University Hospital Virgen de las NievesTerminatedKnee DiscomfortSpain
-
Universidade Federal do AmazonasCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Hospital Universitario... and other collaboratorsCompletedOverweight | HypercholesterolemiaBrazil
-
Larissa University HospitalRecruitingDumping Syndrome | Gastric SurgeryGreece
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
University Hospital OstravaRecruitingCritical Illness | Prolonged Mechanical VentilationCzechia
-
Ultra Botanica LLCActive, not recruitingJoint Discomfort | Quality of Life (QOL)United States
-
NeuroEnergy Ventures, Inc.Active, not recruiting